CHERYL BOSS: Open Payments
NPI 1760436109 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 48 payments from 9 companies in 2025. Trend: 2023 $925 · 2024 $913 · 2025 $802
Food & beverage: $717Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $310 |
| Lilly USA, LLC | 11 | $174 |
| Mannkind Corporation | 2 | $85 |
| Abbott Laboratories | 5 | $83 |
| Insulet Corporation | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Tandem Diabetes Care, Inc. | 2 | $16 |
Products named: MOUNJARO, Rybelsus, AFREZZA, FREESTYLE LIBRE 3, Ozempic, Omnipod, JARDIANCE, Kerendia.
Industry payments across IL — which companies pay providers there.
